The medium and high doses (2 and 4 g raw drug/kg) also significantly increased serum levels of gastrin and motilin in FD rats, upregulated the expression of aquaporin 4 in gastric tissue, and thus improved the gastrointestinal function in the FD rat model (Shen et al., 2019). This evidence concerns the gene AQP4 and Fabry disease.